Gain Therapeutics (GANX) Q1 2025 Earnings

27MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.42
-0.31
-0.19
-0.08

Details

Expected EPS
-0.18365
Actual EPS
-0.08
Surprise EPS
0.1
Surprise Percent
+56.44%

Description

Gain Therapeutics (GANX) has reported earnings of -0.08 per share for Q1 2025.

0 Comments

Share your thoughts